Liver resection for hepatocellular carcinoma in patients with normal or chronic liver disease remains a major therapeutic tool. Its indications keep expanding over the years nevertheless it is still burdened with a significant morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: